HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts.

Abstract
Pancreatic cystic neoplasms represent 10-15% of primary cystic masses of the pancreas. While pancreatic cysts are detected with an increasing frequency due to the use of advanced imaging modalities in clinical practice, the diagnosis of pancreatic cystic neoplasms remains unsatisfactory because available diagnostic techniques proved not sensitive enough so far. This study was designed to characterize the proteomic pattern of pancreatic cyst fluids obtained from various cystic lesions. Cyst fluids were collected by direct puncture during open surgery to avoid any possible contamination from other tissues. CEA, CA-19-9, and amylase concentrations were measured using specific immunoassays. After immunodepletion and fractionation by SDS-PAGE, proteins were digested and analyzed by LC-MS/MS. Specific histological lesions were found to be associated with distinct protein patterns. Interestingly, some of these proteins have been proposed as biomarkers of pancreatic cancer. Immunoblots allowed for verifying the differential expression in specific cyst fluids of two selected proteins, olfactomedin-4 and mucin-18. Finally, immunohistochemistry was performed to correlate these data with the expression pattern of olfactomedin-4 and mucin-18 in pancreatic cyst tissues. Results from this study indicate that proteomic analysis of cyst fluid could provide reliable candidates for developing new biomarkers for the preoperative management of malignant and premalignant pancreatic cysts.
AuthorsAurora Cuoghi, Annarita Farina, Kaspar Z'graggen, Jean-Marc Dumonceau, Aldo Tomasi, Denis F Hochstrasser, Muriel Genevay, Pierre Lescuyer, Jean-Louis Frossard
JournalJournal of proteome research (J Proteome Res) Vol. 10 Issue 5 Pg. 2664-70 (May 06 2011) ISSN: 1535-3907 [Electronic] United States
PMID21425880 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • CA-19-9 Antigen
  • Carcinoembryonic Antigen
  • Mucins
  • OLFM4 protein, human
  • Granulocyte Colony-Stimulating Factor
  • Amylases
Topics
  • Amylases (analysis)
  • Biomarkers, Tumor (analysis)
  • CA-19-9 Antigen (analysis)
  • Carcinoembryonic Antigen (analysis)
  • Chromatography, Liquid
  • Cyst Fluid (chemistry)
  • Electrophoresis, Polyacrylamide Gel
  • Granulocyte Colony-Stimulating Factor (metabolism)
  • Humans
  • Immunoassay
  • Immunoblotting
  • Immunohistochemistry
  • Mucins (metabolism)
  • Pancreatic Cyst (diagnosis, metabolism)
  • Pancreatic Neoplasms (diagnosis, metabolism)
  • Proteomics (methods)
  • Tandem Mass Spectrometry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: